Journal of Cancer Metastasis and Treatment is Included in Embase
We are thrilled to announce that in July 2023, Journal of Cancer Metastasis and Treatment(JCMT) has earned a coveted spot in the latest Embase collection list released by Elsevier.
Embase serves as a gateway to a vast realm of biomedical literature, boasting a repository of over 6 million citations and encompassing more than 2,900 journals that are not found in PubMed. It is renowned for its comprehensive coverage of international biomedical literature, covering critical areas such as drug research, medical device information, and indexing of conference abstracts. There are periodicals from 95 countries participating in the database selection.
This marks yet another milestone for JCMT, adding to its distinguished presence in renowned international databases, including ESCI, Scopus, CAS, and others.
JCMT will continue to strive for excellence, enhancing the quality and standards of the journal. Our mission is to fully harness the journal's pivotal role in advancing academic research, while consistently providing exceptional service in sharing and disseminating groundbreaking research achievements.
